NCT00997984 · Interventional trial
Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)
Overall registry status Completed
Phase 3
Conditions Attention-Deficit/Hyperactivity Disorder
Delaware Valley sites
- CRI Worldwide, LLC · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory